✦ LIBER ✦

Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis

✍ Scribed by Richard Kahn; Peter Alperin; David Eddy; Knut Borch-Johnsen; John Buse; Justin Feigelman; Edward Gregg; Rury R Holman; M Sue Kirkman; Michael Stern; Jaakko Tuomilehto; Nick J Wareham

Book ID: 117306010
Publisher: The Lancet
Year: 2010
Tongue: English
Weight: 365 KB
Volume: 375
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(09)62162-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Maximizing efficiency and cost-effective

Maximizing efficiency and cost-effectiveness of Type 2 diabetes screening: the AusDiab study

✍ L. Chen; D. J. Magliano; B. Balkau; R. Wolfe; L. Brown; A. M. Tonkin; P. Z. Zimm 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 260 KB

A computer simulation model for cost–eff

A computer simulation model for cost–effectiveness analysis of mass screening for Type 2 diabetes mellitus

✍ Tony Hsiu-Hsi Chen; Ming-Fang Yen; Tao-Hsin Tung 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 73 KB

Development of a model to assess the cos

Development of a model to assess the cost-effectiveness of gestational diabetes mellitus screening and lifestyle change for the prevention of type 2 diabetes mellitus

✍ Nicolai Lohse; Elliot Marseille; James G. Kahn 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 233 KB

A cost-effectiveness analysis of a commu

A cost-effectiveness analysis of a community pharmacist-initiated disease state management service for type 2 diabetes mellitus

✍ Dr. Susan J. Taylor; Tsveta Milanova; Fleur Hourihan; Ines Krass; Clare Coleman; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB

TPS2: COST ANALYSIS OF A DIAGNOSTIC SCRE

TPS2: COST ANALYSIS OF A DIAGNOSTIC SCREENING TO DIFFERENTIATE 30- TO 45-YEAR-OLD PATIENTS WITH TYPE 1 AND TYPE 2 DIABETES MELLITUS

✍ A Kilburg; Y Bruchhausen; J Thomas; R Rychlik 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 48 KB

PDB45 COST-EFFECTIVENESS ANALYSIS OF SAX

PDB45 COST-EFFECTIVENESS ANALYSIS OF SAXAGLIPTIN IN THE TREATMENT OF DIABETES MELLITUS TYPE 2 IN SPAIN

✍ de Ramirez; A Arellano; M Brosa; J Franch; D Mauricio; C Alvarez; M Sanchez-Zamo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB